B. Craves Frederick's most recent trade in Madrigal Pharmaceuticals Inc was a trade of 7,742 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on March 12, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Madrigal Pharmaceuticals Inc | Frederick B. Craves | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Mar 2025 | 7,742 | 0 | - | - | Stock Option (Right to Buy) | |
| Madrigal Pharmaceuticals Inc | Frederick B. Craves | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 65.06 per share. | 12 Mar 2025 | 7,742 | 357,818 (2%) | 0% | 65.1 | 503,695 | Common Stock |
| Madrigal Pharmaceuticals Inc | Frederick B. Craves | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Mar 2025 | 6,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Madrigal Pharmaceuticals Inc | Frederick B. Craves | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 111.06 per share. | 12 Mar 2025 | 6,000 | 357,804 (2%) | 0% | 111.1 | 666,360 | Common Stock |
| Madrigal Pharmaceuticals Inc | Frederick B. Craves | Director | Sale of securities on an exchange or to another person at price $ 331.36 per share. | 12 Mar 2025 | 2,759 | 353,458 (2%) | 0% | 331.4 | 914,221 | Common Stock |
| Madrigal Pharmaceuticals Inc | Frederick B. Craves | Director | Sale of securities on an exchange or to another person at price $ 332.38 per share. | 12 Mar 2025 | 2,382 | 351,076 (2%) | 0% | 332.4 | 791,726 | Common Stock |
| Madrigal Pharmaceuticals Inc | Frederick B. Craves | Director | Sale of securities on an exchange or to another person at price $ 322.45 per share. | 12 Mar 2025 | 1,951 | 355,867 (2%) | 0% | 322.5 | 629,100 | Common Stock |
| Madrigal Pharmaceuticals Inc | Frederick B. Craves | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 65.06 per share. | 12 Mar 2025 | 1,728 | 351,804 (2%) | 0% | 65.1 | 112,424 | Common Stock |
| Madrigal Pharmaceuticals Inc | Frederick B. Craves | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Mar 2025 | 1,728 | 7,742 | - | - | Stock Option (Right to Buy) | |
| Madrigal Pharmaceuticals Inc | Frederick B. Craves | Director | Sale of securities on an exchange or to another person at price $ 323.47 per share. | 12 Mar 2025 | 1,649 | 354,218 (2%) | 0% | 323.5 | 533,394 | Common Stock |
| Madrigal Pharmaceuticals Inc | Frederick B. Craves | Director | Sale of securities on an exchange or to another person at price $ 330.54 per share. | 12 Mar 2025 | 1,587 | 356,217 (2%) | 0% | 330.5 | 524,560 | Common Stock |
| Madrigal Pharmaceuticals Inc | Frederick B. Craves | Director | Sale of securities on an exchange or to another person at price $ 327.63 per share. | 12 Mar 2025 | 1,000 | 351,518 (2%) | 0% | 327.6 | 327,627 | Common Stock |
| Madrigal Pharmaceuticals Inc | Frederick B. Craves | Director | Sale of securities on an exchange or to another person at price $ 329.86 per share. | 12 Mar 2025 | 967 | 350,151 (2%) | 0% | 329.9 | 318,975 | Common Stock |
| Madrigal Pharmaceuticals Inc | Frederick B. Craves | Director | Sale of securities on an exchange or to another person at price $ 324.69 per share. | 12 Mar 2025 | 900 | 353,318 (2%) | 0% | 324.7 | 292,218 | Common Stock |
| Madrigal Pharmaceuticals Inc | Frederick B. Craves | Director | Sale of securities on an exchange or to another person at price $ 325.63 per share. | 12 Mar 2025 | 800 | 352,518 (2%) | 0% | 325.6 | 260,501 | Common Stock |
| Madrigal Pharmaceuticals Inc | Frederick B. Craves | Director | Sale of securities on an exchange or to another person at price $ 333.66 per share. | 12 Mar 2025 | 800 | 350,276 (2%) | 0% | 333.7 | 266,926 | Common Stock |
| Madrigal Pharmaceuticals Inc | Frederick B. Craves | Director | Sale of securities on an exchange or to another person at price $ 328.68 per share. | 12 Mar 2025 | 400 | 351,118 (2%) | 0% | 328.7 | 131,472 | Common Stock |
| Madrigal Pharmaceuticals Inc | Frederick B. Craves | Director | Sale of securities on an exchange or to another person at price $ 334.97 per share. | 12 Mar 2025 | 200 | 350,076 (2%) | 0% | 335.0 | 66,994 | Common Stock |
| Madrigal Pharmaceuticals Inc | Frederick B. Craves | Director | Sale of securities on an exchange or to another person at price $ 330.23 per share. | 12 Mar 2025 | 75 | 350,076 (2%) | 0% | 330.2 | 24,767 | Common Stock |
| Madrigal Pharmaceuticals Inc | Craves Frederick B. | Director | 03 Dec 2024 | 3,080 | 11,520 (0%) | 0% | 315.2 | 970,852 | Common Stock | |
| Madrigal Pharmaceuticals Inc | Craves B. Frederick | Director | 03 Dec 2024 | 520 | 11,000 (0%) | 0% | 315.9 | 164,270 | Common Stock | |
| Madrigal Pharmaceuticals Inc | B. Craves Frederick | Director | 25 Nov 2024 | 2,200 | 15,800 (0%) | 0% | 350.1 | 770,171 | Common Stock | |
| Madrigal Pharmaceuticals Inc | Craves B. Frederick | Director | 25 Nov 2024 | 1,200 | 14,600 (0%) | 0% | 350.7 | 420,858 | Common Stock | |
| Madrigal Pharmaceuticals Inc | Frederick B. Craves | Director | 13 Sep 2024 | 15,000 | 360,076 (2%) | 0% | 0 | Common Stock | ||
| Madrigal Pharmaceuticals Inc | Frederick B. Craves | Director | 25 Jun 2024 | 1,105 | 1,105 | - | - | Stock Option (Right to Buy) | ||
| Madrigal Pharmaceuticals Inc | Frederick B. Craves | Director | 25 Jun 2024 | 714 | 375,076 (2%) | 0% | 0 | Common Stock | ||
| Madrigal Pharmaceuticals Inc | Frederick B. Craves | Director | 11 Jun 2024 | 45,852 | 11,210 (0%) | 0% | 0 | Common Stock | ||
| Madrigal Pharmaceuticals Inc | Frederick B. Craves | Director | 11 Jun 2024 | 39,000 | 374,362 (2%) | 0% | 0 | Common Stock | ||
| Madrigal Pharmaceuticals Inc | Frederick B. Craves | Director | 14 May 2024 | 12,489 | 435,851 (2%) | 0% | 105.1 | 1,312,344 | Common Stock | |
| Madrigal Pharmaceuticals Inc | Frederick B. Craves | Director | 14 May 2024 | 12,489 | 0 | - | - | Stock Option (right to buy) | ||
| Madrigal Pharmaceuticals Inc | Frederick B. Craves | Director | 14 May 2024 | 10,000 | 423,362 (2%) | 0% | 100.5 | 1,004,500 | Common Stock | |
| Madrigal Pharmaceuticals Inc | Frederick B. Craves | Director | 14 May 2024 | 10,000 | 0 | - | - | Stock Option (right to buy) | ||
| Madrigal Pharmaceuticals Inc | Frederick B. Craves | Director | 14 May 2024 | 8,827 | 427,024 (2%) | 0% | 211.0 | 1,862,432 | Common Stock | |
| Madrigal Pharmaceuticals Inc | Frederick B. Craves | Director | 14 May 2024 | 5,009 | 422,015 (2%) | 0% | 211.8 | 1,061,127 | Common Stock | |
| Madrigal Pharmaceuticals Inc | Frederick B. Craves | Director | 14 May 2024 | 2,190 | 418,462 (2%) | 0% | 213.9 | 468,342 | Common Stock | |
| Madrigal Pharmaceuticals Inc | Frederick B. Craves | Director | 14 May 2024 | 1,804 | 416,658 (2%) | 0% | 214.7 | 387,285 | Common Stock | |
| Madrigal Pharmaceuticals Inc | Frederick B. Craves | Director | 14 May 2024 | 1,363 | 420,652 (2%) | 0% | 212.9 | 290,116 | Common Stock | |
| Madrigal Pharmaceuticals Inc | Frederick B. Craves | Director | 14 May 2024 | 1,100 | 414,462 (2%) | 0% | 217.9 | 239,641 | Common Stock | |
| Madrigal Pharmaceuticals Inc | Frederick B. Craves | Director | 14 May 2024 | 1,000 | 413,462 (2%) | 0% | 219.0 | 218,995 | Common Stock | |
| Madrigal Pharmaceuticals Inc | Frederick B. Craves | Director | 14 May 2024 | 721 | 415,562 (2%) | 0% | 217.0 | 156,445 | Common Stock | |
| Madrigal Pharmaceuticals Inc | Frederick B. Craves | Director | 14 May 2024 | 375 | 416,283 (2%) | 0% | 216.1 | 81,031 | Common Stock | |
| Madrigal Pharmaceuticals Inc | Frederick B. Craves | Director | 14 May 2024 | 100 | 413,362 (2%) | 0% | 219.9 | 21,990 | Common Stock | |
| Madrigal Pharmaceuticals Inc | Frederick B. Craves | Director | 07 Dec 2023 | 1,510,521 | 0 (0%) | 9% | 0 | Common Stock | ||
| Madrigal Pharmaceuticals Inc | Frederick B. Craves | Director | 07 Dec 2023 | 46,073 | 1,261 (0%) | 0% | 0 | Common Stock | ||
| Madrigal Pharmaceuticals Inc | Craves Frederick B. | Director | 07 Dec 2023 | 3,557 | 57,062 (0%) | 0% | 0 | Common Stock | ||
| Madrigal Pharmaceuticals Inc | Frederick B. Craves | Director | 15 Jun 2023 | 1,198 | 362,556 (2%) | 0% | 0 | Common Stock | ||
| Madrigal Pharmaceuticals Inc | Frederick B. Craves | Director | 16 Jun 2022 | 9,470 | 9,470 | - | - | Stock Option (Right to Buy) | ||
| Madrigal Pharmaceuticals Inc | Frederick B. Craves | Director | 17 Jun 2021 | 12,489 | 12,489 | - | - | Stock Option (Right to Buy) | ||
| Madrigal Pharmaceuticals Inc | Frederick B. Craves | Director, Ten Percent Owner | 04 Sep 2020 | 1,468,350 | 2,260,791 (14%) | 9% | 0 | Common Stock | ||
| Madrigal Pharmaceuticals Inc | Frederick B. Craves | Director, Ten Percent Owner | 04 Sep 2020 | 45,460 | 43,537 (0%) | 0% | 0 | Common Stock | ||
| Madrigal Pharmaceuticals Inc | Frederick B. Craves | Director, Ten Percent Owner | 04 Sep 2020 | 31,650 | 49,730 (0%) | 0% | 0 | Common Stock | ||
| Madrigal Pharmaceuticals Inc | Frederick B. Craves | Director, Ten Percent Owner | 17 Aug 2020 | 12,500 | 60,375 (0%) | 0% | 110.7 | 1,384,125 | Common Stock | |
| Madrigal Pharmaceuticals Inc | Frederick B. Craves | Director, Ten Percent Owner | 17 Aug 2020 | 10,197 | 50,178 (0%) | 0% | 110.0 | 1,121,976 | Common Stock | |
| Madrigal Pharmaceuticals Inc | Frederick B. Craves | Director, Ten Percent Owner | 17 Aug 2020 | 7,303 | 42,875 (0%) | 0% | 107.6 | 786,095 | Common Stock |